Expertise in
8
conditions

Dr. Andras Perl

Rheumatology
Department Of Medicine Medical Service Group
1000 E Genesee St Ste 403, 
Syracuse, NY 
Accepting New Patients
Expertise in
8
conditions
Department Of Medicine Medical Service Group
1000 E Genesee St Ste 403, 
Syracuse, NY 

Overview

Andras Perl is a Rheumatologist practicing medicine in Syracuse, New York.

Dr. Perl is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Psoriatic Arthritis, Discoid Lupus Erythematosus (DLE), Psoriasis, and Thymectomy.

He is actively involved in clinical research, co-authoring 105 peer reviewed articles and participating in 7 clinical trials. Dr. Perl is currently accepting new patients.

Specialties

Rheumatology

Licenses

Internal Medicine in NY

Hospital Affiliations

University Hospital S U N Y Health Science Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Department of Medicine Medical Service Group
1000 E Genesee St Ste 403, Syracuse, NY 13210

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine (NAC) (SNAC)
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine (NAC) (SNAC)
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 20, 2025
Intervention Type: Drug
Study Drug: LY3361237
Study Phase: Phase 2
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: July 23, 2024
Intervention Type: Drug, Other
Study Drug: VIB7734
Study Phase: Phase 2
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: March 29, 2024
Intervention Type: Drug
Study Drug: TAK-079
Study Phase: Phase 1
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: November 23, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
Enrollment Status: Terminated
Publish Date: April 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

105 Total Publications

Hepatic control of immunometabolism: implications for the pathogenesis, diagnosis and treatment of rheumatic diseases.
Hepatic control of immunometabolism: implications for the pathogenesis, diagnosis and treatment of rheumatic diseases.
Journal: Nature reviews. Rheumatology
Published: July 29, 2026
Similar Doctors
Expertise in
27
conditions
Dr. Hom P. Neupane
Rheumatology
Expertise in
27
conditions
Dr. Hom P. Neupane
Rheumatology
Referral may be required
Before you request

SUNY Upstate

90 Presidential Plz, 
Syracuse, NY 
 (1.4 miles away)
315-464-3836
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Hom Neupane is a Rheumatologist practicing medicine in Syracuse, New York. Dr. Neupane is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Undifferentiated Connective Tissue Disease (UCTD), Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA), and Fibromyalgia. Dr. Neupane is currently accepting new patients.

Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required
Before you request

Arthritis Health Associates PLLC

5794 Widewaters Pkwy, 
Syracuse, NY 
 (3.7 miles away)
315-422-1513
Languages Spoken:
English
See accepted insurances
Accepting New Patients

George Mtanos is a Rheumatologist practicing medicine in Syracuse, New York. Dr. Mtanos is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and MASS Phenotype. Dr. Mtanos is currently accepting new patients.

Expertise in
14
conditions
Expertise in
14
conditions
Referral may be required
Before you request

Arthritis Health Associates PLLC

5794 Widewaters Pkwy, 
Syracuse, NY 
 (3.7 miles away)
315-422-1513
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ramzi Khairallah is a Rheumatologist practicing medicine in Syracuse, New York. Dr. Khairallah is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and Ankylosing Spondylitis. Dr. Khairallah is currently accepting new patients.

Frequently Asked Questions about Dr. Andras Perl

How do I make an appointment with Dr. Andras Perl?

You can book an appointment with Dr. Andras Perl by calling their office at 315-464-2929. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Andras Perl a top-rated expert for Systemic Lupus Erythematosus (SLE)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Andras Perl is classified as an Elite expert for Systemic Lupus Erythematosus (SLE), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Andras Perl specialize in?

While Dr. Andras Perl is a Rheumatology, they have specific expertise in Systemic Lupus Erythematosus (SLE), Psoriatic Arthritis, and Discoid Lupus Erythematosus (DLE). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Andras Perl participate in research or clinical trials?

Yes. Dr. Andras Perl has published 105 articles and abstracts on conditions like Systemic Lupus Erythematosus (SLE). You can view a list of Dr. Andras Perl's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Andras Perl accept my insurance?

Dr. Andras Perl accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 315-464-2929 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Perl's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 23 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile